Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) issued its quarterly earnings results on Wednesday. The technology company reported $1.95 earnings per share (EPS) for the quarter, Zacks reports. Kewaunee Scientific had a return on equity of 26.69% and a net margin of 4.74%. The firm had revenue of $77.15 million during the quarter.
Kewaunee Scientific Trading Up 3.4%
KEQU traded up $1.87 during trading on Friday, hitting $56.67. 41,524 shares of the stock were exchanged, compared to its average volume of 23,306. The firm has a 50 day simple moving average of $37.06 and a 200 day simple moving average of $47.46. The firm has a market cap of $161.51 million, a price-to-earnings ratio of 14.80 and a beta of 0.56. Kewaunee Scientific has a 1 year low of $30.33 and a 1 year high of $71.33. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.54 and a current ratio of 2.16.
Insiders Place Their Bets
In other news, Director Keith M. Gehl acquired 1,000 shares of Kewaunee Scientific stock in a transaction on Friday, April 4th. The shares were bought at an average cost of $35.00 per share, for a total transaction of $35,000.00. Following the acquisition, the director now directly owns 18,500 shares of the company's stock, valued at $647,500. This trade represents a 5.71% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Thomas David Hull III sold 1,844 shares of the firm's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $32.44, for a total value of $59,819.36. Following the transaction, the chief executive officer now owns 36,072 shares in the company, valued at $1,170,175.68. The trade was a 4.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 14.20% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of KEQU. Goldman Sachs Group Inc. raised its position in shares of Kewaunee Scientific by 125.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company's stock worth $764,000 after acquiring an additional 10,803 shares in the last quarter. Jane Street Group LLC raised its position in shares of Kewaunee Scientific by 65.8% in the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company's stock worth $317,000 after acquiring an additional 3,196 shares in the last quarter. Finally, Bank of America Corp DE raised its position in shares of Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after acquiring an additional 443 shares in the last quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Friday, March 14th.
Get Our Latest Stock Report on Kewaunee Scientific
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.